tiprankstipranks
OKYO Pharma (EMMLF)
OTHER OTC:EMMLF
Holding EMMLF?
Track your performance easily

OKYO Pharma (EMMLF) Financial Statements

2 Followers

OKYO Pharma Financial Overview

OKYO Pharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; OKYO Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Mar 22Sep 21Mar 21Sep 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 633.63K£ 2.70M£ 3.85M£ 4.99M£ 5.76M
Total Assets£ 1.59M£ 4.30M£ 4.18M£ 5.14M£ 5.84M
Total Debt£ 0.00£ 0.00£ 60.73K£ 71.56K£ 22.52K
Net Debt£ -633.63K£ -2.70M£ -3.79M£ -4.92M£ -5.74M
Total Liabilities£ 1.90M£ 1.35M£ 494.83K£ 1.28M£ 342.75K
Stockholders Equity£ -309.68K£ 2.95M£ 3.68M£ 3.85M£ 5.50M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

OKYO Pharma Earnings and Revenue History

OKYO Pharma Debt to Assets

OKYO Pharma Cash Flow

OKYO Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis